Characteristics of patients with stage III and IV ovarian endometriomas and trends in postoperative anti-Mullerian hormone changes

Kefei Gao,Wenqin Lian,Rui Zhao,Jian Xiong
DOI: https://doi.org/10.5114/aoms/162114
2023-05-01
Archives of Medical Science
Abstract:Introduction This study aimed to investigate the manifestations of postoperative Anti-Mullerian hormone (AMH) changes in patients with stage III and IV ovarian endometriomas. Material and methods Trends in postoperative AMH were categorized and described, and the risk factors for postoperative AMH decline were screened using dichotomous logistic regression. Results The overall trend of postoperative AMH decreased, with a more significant decrease in stage IV than stage III cases. Elevated preoperative CA-125 levels, a history of caesarean section, and abortion were independent risk factors for postoperative AMH decline. Conclusions There is a general trend toward decreasing AMH levels after surgery, but each case may also show a different elevation.
medicine, general & internal
What problem does this paper attempt to address?